Roxana Mehran

About Roxana Mehran

Roxana Mehran, With an exceptional h-index of 179 and a recent h-index of 109 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions

Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: an analysis from the WIN-TAVI cohort

Femoral vascular closure devices and bleeding, hemostasis, and ambulation following percutaneous coronary intervention

Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI

The mega COMBO collaboration: an individual patient data pooled analysis of patients undergoing PCI with COMBO stent

Validation of UK-BCIS CHIP score to predict 1-year outcomes in a contemporary United States population

Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO‐3 randomized trial

B-6| Prognostic Impact of Procedural Complexity in Octogenarians Undergoing Percutaneous Coronary Intervention

Roxana Mehran Information

University

Position

___

Citations(all)

245044

Citations(since 2020)

104733

Cited By

183703

hIndex(all)

179

hIndex(since 2020)

109

i10Index(all)

1014

i10Index(since 2020)

711

Email

University Profile Page

Google Scholar

Roxana Mehran Skills & Research Interests

Medicine

Top articles of Roxana Mehran

P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions

Journal of the American College of Cardiology

2023/2/14

Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: an analysis from the WIN-TAVI cohort

International journal of cardiology

2023/2/1

Femoral vascular closure devices and bleeding, hemostasis, and ambulation following percutaneous coronary intervention

Journal of the American Heart Association

2023/1/3

Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI

2023

The mega COMBO collaboration: an individual patient data pooled analysis of patients undergoing PCI with COMBO stent

International journal of cardiology

2023/1/1

Validation of UK-BCIS CHIP score to predict 1-year outcomes in a contemporary United States population

Cardiovascular Interventions

2023/5/8

Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO‐3 randomized trial

Journal of the American College of Cardiology

2022/4/3

B-6| Prognostic Impact of Procedural Complexity in Octogenarians Undergoing Percutaneous Coronary Intervention

Journal of the Society for Cardiovascular Angiography & Interventions

2023/5/1

Clinical pharmacokinetics and pharmacodynamics of CSL112

2022/7

Representation of Women in Cardiology Academic Faculty Ranks

American journal of cardiology

2023/3/1

Roxana Mehran
Roxana Mehran

H-Index: 104

Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials

European Heart Journal-Cardiovascular Pharmacotherapy

2023/3

Roxana Mehran
Roxana Mehran

H-Index: 104

Prevention and management of stroke after transcatheter aortic valve replacement: the Mount Sinai stroke initiative

Journal of the American Heart Association

2023/2/21

Roxana Mehran
Roxana Mehran

H-Index: 104

Clinical Outcomes of PCI With a Zotarolimus-Eluting Stent Followed by One-Month DAPT in High-Bleeding-Risk Patients With Small (≤ 2.5 mm) Coronary Arteries: One-Year Analysis …

Cardiovascular Revascularization Medicine

2022/7/1

Rationale and design of the Small Annuli Randomized to Evolut or SAPIEN Trial (SMART trial)

American heart journal

2022/1/1

Antiplatelet therapy in patients undergoing elective percutaneous coronary intervention

2022/3

Roxana Mehran
Roxana Mehran

H-Index: 104

Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis …

2022/11

White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial

Coronary artery disease

2022/1/1

Efficacy and safety considerations with dose-reduced direct oral anticoagulants: a review

2022/7/1

Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials

2022/11

Sex differences in outcomes after percutaneous coronary intervention or coronary artery bypass graft for left main disease: from the DELTA Registries

Journal of the American Heart Association

2022/3/1

See List of Professors in Roxana Mehran University(Icahn School of Medicine at Mount Sinai)